Edward P. Jordan - Jun 8, 2021 Form 4 Insider Report for HUMANIGEN, INC (HGEN)

Role: Chief Commercial Officer
Signature: /s/ Timothy E. Morris, Attorney-in-fact
Stock symbol: HGEN
Transactions as of: Jun 8, 2021
Transactions value $: -$153,321
Form type: 4
Date filed: 6/9/2021, 05:10 PM
Next filing: Oct 4, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HGEN	Common Stock	Options Exercise	$142K	+14.7K		$9.65	14.7K	Jun 8, 2021	Direct
transaction	HGEN	Common Stock	Sale	-$295K	-14.7K	-100%	$20.08	0	Jun 8, 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HGEN	Stock Option (Right to Buy)	Options Exercise	$0	-14.7K	-16.67%	$0.00	73.5K	Jun 8, 2021	Common Stock	14.7K	$9.65	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On September 18, 2020, Mr. Jordan was granted an option to purchase 88,200 shares of the Company's common stock, which vests in 12 ratable quarterly installments commencing December 31, 2020.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.21, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).

Content

On September 18, 2020, Mr. Jordan was granted an option to purchase 88,200 shares of the Company's common stock, which vests in 12 ratable quarterly installments commencing December 31, 2020.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.21, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).